Enzymatica develops solutions that support the body's own defenses against virus, irritants and microorganisms.
the science
that protects
press
releases
All press releases
- November 16, 2022 - Non-regulatory press releasesEnzymatica and University of Kent launch study to explore prevention of upper respiratory virus infections in elite athletes
- November 2, 2022 - Regulatory press releasesInterim report Q3/2022: A broader role for ColdZyme adds potential for the future
- November 1, 2022 - Non-regulatory press releasesNew study confirms ColdZyme stops viruses causing Covid-19 from adhering to human respiratory cells
financial
reports
All reports
financial
calendar
All events
- February 17, 2023Interim report, Jan–Dec 2022
- April 5, 20232022 Annual Report
- April 27, 2023Interim report, Jan–March 2023
enzyme science
Research has shown that in some cold-adapted marine organisms such as cod there is an enzyme with good protective properties.
research& development
Enzymatica focuses on product development based on the tested and patented barrier technology used in the common cold product ColdZyme.
Find out more
sustainability
Health and well-being constitute the foundation of our company, and we want to use resources wisely and sustainably.
Find out more